Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms. - Wikidata - awgldk - TriplyDB

Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.

Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.

http://www.wikidata.org/entity/Q37641588

about

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy.Genetic Transformation System for Woody Plant Tripterygium wilfordii and Its Application to Product Natural Celastrol.Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model.Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide.Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds.Inhibitory effects of isocryptotanshinone on gastric cancer.Detoxication mechanisms of Radix Tripterygium wilfordii via compatibility with Herba Lysimachia christinae in S180-bearing mice by involving Nrf2.Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis

P2860

Q47193745-3E429CD8-0685-4F69-99FB-738042DC313C Q49364060-3905DD76-5570-46BE-897D-23452D907F66 Q49520967-AE393470-E75C-4FAA-943E-C935F123039A Q49703778-7BCFED64-49E8-48E4-BCCA-D5F5E46F0425 Q54987090-A6720C18-1451-4D4C-B0A8-A1C012E3BE32 Q55343616-39754E73-0A5F-413D-B558-A05D6CE94042 Q55717443-3324E0CC-4084-4377-92E9-CB06F9B7011D Q57283070-BA77A34E-4BB9-4B78-B6DD-7E34037F78B1

P2860

Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.

http://www.wikidata.org/entity/Q37641588

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@en

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@nl

type

label

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@en

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@nl

prefLabel

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@en

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@nl

P1433

Q37641588-77719D82-7382-4667-AEDC-AB6FC72B371C

P1476

Q37641588-9F090AE7-CBEE-410A-A11D-F01FB38540C8

P2093

Q37641588-09D18A44-6691-4F64-8BA6-F5697F315DAB

Q37641588-0D4E99F6-9D00-4298-9A68-8A8C57A0EE63

Q37641588-168B1A20-2EF4-409B-B51B-E5707E87BEA7

Q37641588-478284D6-DC3B-40ED-810C-52AB50C79E74

Q37641588-5F4F8D7B-0A6F-4771-9FA1-749E7C71775C

Q37641588-641E35EF-24BB-421A-A6CC-3B2C3A6AF16D

Q37641588-6D37C695-2DB2-4D3E-99E2-5EEB86B1ED0B

Q37641588-7AE9EE26-A7C8-4184-8650-DFA9EF325B00

Q37641588-7BE375C5-FB0D-4237-80CE-D90DDBB96016

Q37641588-AB34DAAC-16A4-4818-926A-80AB4EB9EBC6

P2860

Q37641588-0144A4E5-676A-4564-A308-74D57F28A7D9

Q37641588-0449D4D5-F898-43F4-AB2F-B88F865A25F9

Q37641588-076034AC-7E2B-48AA-B974-EC2A92487802

Q37641588-0974E9C5-DB56-424D-8282-9B9DA30C24E3

Q37641588-0A1002BC-8851-434D-B5FF-110C0DBD1B07

Q37641588-0C6285A3-E0DC-47CD-A771-B1667A8DB6E4

Q37641588-1265281B-C656-4797-97F7-0928A367D45B

Q37641588-1399530A-1457-4598-8174-C54B77134CFA

Q37641588-1A1DFC7C-8109-4976-B5E1-95709DC7B905

Q37641588-1B8FF183-D8F1-4A7C-BAA7-0FDF758512F9

P304

Q37641588-BB0C5AD7-36D9-4D7D-842B-4B1EF240C9A3

P31

Q37641588-24A12EC9-0E3E-4BBA-9D52-77294CF05088

P356

Q37641588-497582A8-1E53-4098-BF73-368084E4ACA8

P407

Q37641588-9E1118F3-80E7-43F9-85D8-FF6448BAC965

P433

Q37641588-0ABDE8C5-3F9C-45A9-83A0-1BA668CE764A

P478

Q37641588-C88483BD-91C5-4A76-A0AD-3B512BBE410D

P577

Q37641588-D93142AE-851B-4EF1-B8B1-FBC274F6B077

P698

Q37641588-A7C6C9D2-625C-4E28-9C56-8A1C2BE2B196

P932

Q37641588-EB6CE982-E26C-471C-ACC5-94F1764CB804

P356

ONCOTARGET.10868

P1433

P1476

Overcoming chemoresistance in ...... ordii via multiple mechanisms.

@en

P2093

Bernard Lau

http://www.w3.org/2001/XMLSchema#string

Christopher Wai Kei Lam

http://www.w3.org/2001/XMLSchema#string

Jeffrey Wang

http://www.w3.org/2001/XMLSchema#string

Jijun Hao

http://www.w3.org/2001/XMLSchema#string

Leming Shi

http://www.w3.org/2001/XMLSchema#string

Mandy Liu

http://www.w3.org/2001/XMLSchema#string

Moses Sing Sum Chow

http://www.w3.org/2001/XMLSchema#string

Ranadheer Ravula

http://www.w3.org/2001/XMLSchema#string

Steven Yeung

http://www.w3.org/2001/XMLSchema#string

Ying Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map

Nrf2 pathway regulates multidrug-resistance-associated protein 1 in small cell lung cancer

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer

Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model

Hematotoxicity of the chinese herbal medicine Tripterygium wilfordii hook f in CD34-positive human bone marrow cells.

Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB

Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity.

New strategy to control cell migration and metastasis regulated by CCN2/CTGF.

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.

Clinical review 134: The endocrinology of prostate cancer.

P304

61246-61261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10868

http://www.w3.org/2001/XMLSchema#string

P407

P433

38

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27487134

http://www.w3.org/2001/XMLSchema#string

P932

5308648

http://www.w3.org/2001/XMLSchema#string